Cardiomyopathy Clinical Trials
Feel free to call or e-mail the Knight Cardiovascular Institute research team at 503-418-1964 or by emailing email@example.com. You will then be forwarded to the appropriate research team member who will be able to see if you qualify for any of the clinical trials being offered at OHSU.
You can also find all the of heart failure clinical trials, that are currently enrolling patients, below.
Clinical Trial Name
|BeAT-HF: Barostim Neo® - Baroflex Activation Therapy for Heart Failure||Albert Camacho, MD|| ||IRB00015725|
|CAPACITY-HF: - A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 over 12 Weeks in Patients with Heart Failure with Preserved Ejection Fraction (CAPACITY HFpEF)||Albert Camacho, MD||Catherine Wong, MD / Jayne Mitchell, ANP-BC, CHFN||IRB00017719|
|HCM Pilot Study: Hypertrophic Cardiomyopathy Pilot Study||Larisa Tereshchenko, MD, PhD||Stephen Heitner, MD||IRB00015049|
|LIFE STUDY: Entresto™(LCZ696) in Advance Heart Failure||Albert Camacho, MD||IRB00016277|
|MAVERICK-HCM: A Randomized, Double-blind, Pacebo-controlled, Concentration-guided, Exploratory Study of Mavacamten (MYK-461) in Patients with Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction||Stephen Heitner, MD||Babak Nazer, MD / Erin Boehm, MD / Katherine Bischof, PA-C / Lidija Breznikar McGrath, MD / Michael Shapiro, DO / Mrinal Yadava, MD / Ryan Von Woerkom, MD / Steven Mansoor, MD, PhD / Thomas Dewland, MD / Vaughn Tuchy, MD||IRB00018173|
MOMENTUM 3: Multi-Center Study of Maglev Technology in Patients Undergoing MCS Therapy in HeartMate 3
|Frederick Tibayan, MD ||IRB00016427|
MYK-491-003 HF-SAD: Randomized, Double-blind, Crossover, Placebo-controlled, Adaptive Design Study of Safety, Tolerability, Preliminary Pharmacokinetics, and Pharmacodynamics of Single Ascending Oral Doses of MYK-491 in Patients with Stable Heart Failure
|Albert Camacho, MD||Stephen Heitner, MD||IRB00017910|